Title for MeetingAbstracts
Alphabetical listing of titles
CD8 and Il-2R solubles in HIV infection.
CD8 antiviral activity: induction by immunization with NYVAC-SIV recombinant and influence on disease progression.
CD8 as a receptor for primary human immuno-deficiency virus 1 (HIV-1).
CD8 cells restrain progression of AIDS and prognosticate its outcome.
CD8 hyperlymphocytosis in 17 HIV patients.
CD8 hyperlymphocytosis in 70 HIV-infected patients: clinical, biological and evolutive features, Bordeaux, France, 1985-1990.
CD8 lymphocyte activation antigen expression in HIV infection: comparative two- and three-color flow cytometric studies.
CD8 lymphocyte activation in HIV infected newborn infants: risk for early positive HIV cultures and depressed CD4+ lymphocytes.
CD8 lymphocyte counts and serum IGA levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years follow up.
CD8 lymphocyte subsets provide prognostic measures of HIV disease progression.
CD8 lymphocytosis and HIV infection progression.
CD8 mediated suppression generated in macaques following vaccination with SIV GP160 does not affect viral load after challenge.
CD8 subsets in HIV infected women in relation to disease and IDU Status: cross-sectional evaluation of the HIV epidemiological research study (HERS).
CD8 T cell clonal expansions in association with disease state in HIV-infected children.
CD8 T cell dynamics during ART in late-stage HIV disease.
CD8 T cell killing mediated by macrophages via TNFalpha/TNF receptor 2 interactions during HIV infection.
CD8 T cell populations in anti-HIV gag cytotoxic T cell activity.
CD8 T cell-mediated suppression of HIV-1 is enhanced in patients receiving stavudine/indinavir therapy.
CD8 T cells responding to lab-strain HIV recognize autologous virus-infected targets in asymptomatic subjects but not in subjects with more advanced disease.
CD8 T lymphocyte-mediated suppression of HIV-1 LTR-mediated transcription shows no correlation with clinical stage of disease or health status.
CD8 T-cell anti-HIV activity, but not C-C chemokine levels, is associated with plasma viremia levels in donors of endogenously infected CD4 cells.
CD8+ -cell-mediated in vitro resistance to HIV-1 in early disease.
CD8+ and CD4+ responses to HIV-1 antigens in mice immunized with vaccinia virus (VV) recombinants.
CD8+ anti-HIV suppressor activity (CASA) appears to be driven by viral load: improved immune responses and reduced CASA are observed in patients with undetectable viral loads.
CD8+ associated suppression of in vitro SRV-1 production is mediated by a non-specific soluble factor.
CD8+ CD57+ suppressor T cells release a soluble suppressor factor in HIV infected patients.
CD8+ cell decline in HIV-infected children in a trial of intravenous immunoglobulin (IG). The NICHD IG Trial Group.
CD8+ cell non-cytotoxic anti-HIV immune response inhibits viral transcription and not early steps in virus infection.
CD8+ cell noncytotoxic anti-HIV activity is reduced in acutely infected individuals on HAART therapy.
CD8+ cell suppression of HIV occurs in lymphoid tissues as well as in peripheral blood of HIV-infected individuals.